Safety Evaluation of Advantage Anti-Caries Varnish
Primary Purpose
Dental Caries
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Varnish
Sponsored by
About this trial
This is an interventional prevention trial for Dental Caries
Eligibility Criteria
Inclusion Criteria:
- Healthy
Exclusion Criteria:
- Weight less than 15 kg or hypersensitivity to iodine
Sites / Locations
- University of Washington Regional Clinical Dental Research Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Varnish
Arm Description
Dental varnish containing povidone iodine and sodium fluoride
Outcomes
Primary Outcome Measures
Soft Tissue
Proportion of participants with any oral ulcerations OR inflammatory response
Secondary Outcome Measures
Adverse Events
Proportion of participants with any emergency medical care OR report of nausea OR not eating OR vomiting OR difficulty swallowing OR swelling around the mouth OR itchiness around the mouth OR hives OR rash OR stomach ache OR diarrhea
Full Information
NCT ID
NCT02645617
First Posted
December 28, 2015
Last Updated
January 15, 2020
Sponsor
Advantage Dental Services, LLC
1. Study Identification
Unique Protocol Identification Number
NCT02645617
Brief Title
Safety Evaluation of Advantage Anti-Caries Varnish
Official Title
Phase 1 Safety Evaluation of Advantage Anti-Caries Varnish
Study Type
Interventional
2. Study Status
Record Verification Date
January 2020
Overall Recruitment Status
Completed
Study Start Date
March 30, 2016 (Actual)
Primary Completion Date
September 30, 2016 (Actual)
Study Completion Date
October 20, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Advantage Dental Services, LLC
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.
Detailed Description
This is an open-label Phase 1 study. The active ingredients are Povidone Iodine and Sodium Fluoride [Therametrics Technologies, Inc, Noblesville, IN, USA]. The oral soft tissues and teeth of the children will be examined and the test varnish to the teeth. The child will be re-examined at 24-48 hours for the presence of adverse oral soft tissue changes. At the follow-up, a qualified dental provider will ask questions focused on adverse events.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Varnish
Arm Type
Experimental
Arm Description
Dental varnish containing povidone iodine and sodium fluoride
Intervention Type
Drug
Intervention Name(s)
Varnish
Other Intervention Name(s)
Advantage Anti-Caries Varnish
Intervention Description
Topical application to the teeth
Primary Outcome Measure Information:
Title
Soft Tissue
Description
Proportion of participants with any oral ulcerations OR inflammatory response
Time Frame
within 48 hours
Secondary Outcome Measure Information:
Title
Adverse Events
Description
Proportion of participants with any emergency medical care OR report of nausea OR not eating OR vomiting OR difficulty swallowing OR swelling around the mouth OR itchiness around the mouth OR hives OR rash OR stomach ache OR diarrhea
Time Frame
within 48 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
36 Months
Maximum Age & Unit of Time
60 Months
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy
Exclusion Criteria:
Weight less than 15 kg or hypersensitivity to iodine
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Milgrom, DDS
Organizational Affiliation
Advantage Dental
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington Regional Clinical Dental Research Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98112
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Safety Evaluation of Advantage Anti-Caries Varnish
We'll reach out to this number within 24 hrs